Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Endotracheal tube mucus as a source of airway mucus for rheological study.

Markovetz MR, Subramani DB, Kissner WJ, Morrison CB, Garbarine IC, Ghio A, Ramsey KA, Arora H, Kumar P, Nix DB, Kumagai T, Krunkosky TM, Krause DC, Radicioni G, Alexis NE, Kesimer M, Tiemeyer M, Boucher RC, Ehre C, Hill DB.

Am J Physiol Lung Cell Mol Physiol. 2019 Oct 1;317(4):L498-L509. doi: 10.1152/ajplung.00238.2019. Epub 2019 Aug 7.

PMID:
31389736
2.

Sialylated Receptor Setting Influences Mycoplasma pneumoniae Attachment and Gliding Motility.

Williams CR, Chen L, Driver AD, Arnold EA, Sheppard ES, Locklin J, Krause DC.

Mol Microbiol. 2018 Sep;109(6):735-744. doi: 10.1111/mmi.13997. Epub 2018 Sep 30.

3.

Electron cryotomography of Mycoplasma pneumoniae mutants correlates terminal organelle architectural features and function.

Krause DC, Chen S, Shi J, Jensen AJ, Sheppard ES, Jensen GJ.

Mol Microbiol. 2018 May;108(3):306-318. doi: 10.1111/mmi.13937. Epub 2018 Mar 11.

4.

Modelling persistent Mycoplasma pneumoniae infection of human airway epithelium.

Prince OA, Krunkosky TM, Sheppard ES, Krause DC.

Cell Microbiol. 2018 Mar;20(3). doi: 10.1111/cmi.12810. Epub 2017 Dec 22.

5.

Versatile Methodology for Glycosurfaces: Direct Ligation of Nonderivatized Reducing Saccharides to Poly(pentafluorophenyl acrylate) Grafted Surfaces via Hydrazide Conjugation.

Chen L, Leman D, Williams CR, Brooks K, Krause DC, Locklin J.

Langmuir. 2017 Sep 5;33(35):8821-8828. doi: 10.1021/acs.langmuir.7b00779. Epub 2017 May 18.

6.

VARIABLE SELECTION AND BIOMARKER CORRELATION IN THE ANALYSIS OF MYCOPLASMA PNEUMONIAE STRAINS BY SURFACE-ENHANCED RAMAN SPECTROSCOPY.

Krause DC, Hennigan SL, Henderson KC, Clark HJ, Dluhy RA.

Anal Lett. 2017;50(15):2412-2425. doi: 10.1080/00032719.2017.1287713. Epub 2017 Sep 12.

7.

Specificity and Strain-Typing Capabilities of Nanorod Array-Surface Enhanced Raman Spectroscopy for Mycoplasma pneumoniae Detection.

Henderson KC, Benitez AJ, Ratliff AE, Crabb DM, Sheppard ES, Winchell JM, Dluhy RA, Waites KB, Atkinson TP, Krause DC.

PLoS One. 2015 Jun 29;10(6):e0131831. doi: 10.1371/journal.pone.0131831. eCollection 2015.

8.

The multivariate detection limit for Mycoplasma pneumoniae as determined by nanorod array-surface enhanced Raman spectroscopy and comparison with limit of detection by qPCR.

Henderson KC, Sheppard ES, Rivera-Betancourt OE, Choi JY, Dluhy RA, Thurman KA, Winchell JM, Krause DC.

Analyst. 2014 Dec 21;139(24):6426-34. doi: 10.1039/c4an01141d.

9.

Mycoplasma pneumoniae modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins.

Hao Y, Kuang Z, Jing J, Miao J, Mei LY, Lee RJ, Kim S, Choe S, Krause DC, Lau GW.

Infect Immun. 2014 Dec;82(12):5246-55. doi: 10.1128/IAI.01989-14. Epub 2014 Oct 6.

10.

Layer-by-layer polyelectrolyte encapsulation of Mycoplasma pneumoniae for enhanced Raman detection.

Rivera-Betancourt OE, Sheppard ES, Krause DC, Dluhy RA.

Analyst. 2014 Sep 7;139(17):4287-95. doi: 10.1039/c4an00596a. Epub 2014 Jul 14.

11.

In vitro spatial and temporal analysis of Mycoplasma pneumoniae colonization of human airway epithelium.

Prince OA, Krunkosky TM, Krause DC.

Infect Immun. 2014 Feb;82(2):579-86. doi: 10.1128/IAI.01036-13. Epub 2013 Nov 18.

12.

Protein kinase/phosphatase function correlates with gliding motility in Mycoplasma pneumoniae.

Page CA, Krause DC.

J Bacteriol. 2013 Apr;195(8):1750-7. doi: 10.1128/JB.02277-12. Epub 2013 Feb 8.

13.

P65 truncation impacts P30 dynamics during Mycoplasma pneumoniae gliding.

Hasselbring BM, Sheppard ES, Krause DC.

J Bacteriol. 2012 Jun;194(11):3000-7. doi: 10.1128/JB.00091-12. Epub 2012 Apr 27.

14.

Vaccination of BALB/c mice with an avirulent Mycoplasma pneumoniae P30 mutant results in disease exacerbation upon challenge with a virulent strain.

Szczepanek SM, Majumder S, Sheppard ES, Liao X, Rood D, Tulman ER, Wyand S, Krause DC, Silbart LK, Geary SJ.

Infect Immun. 2012 Mar;80(3):1007-14. doi: 10.1128/IAI.06078-11. Epub 2012 Jan 17.

15.

Detection and differentiation of avian mycoplasmas by surface-enhanced Raman spectroscopy based on a silver nanorod array.

Hennigan SL, Driskell JD, Ferguson-Noel N, Dluhy RA, Zhao Y, Tripp RA, Krause DC.

Appl Environ Microbiol. 2012 Mar;78(6):1930-5. doi: 10.1128/AEM.07419-11. Epub 2011 Dec 30.

16.

Processing is required for a fully functional protein P30 in Mycoplasma pneumoniae gliding and cytadherence.

Chang HY, Prince OA, Sheppard ES, Krause DC.

J Bacteriol. 2011 Oct;193(20):5841-6. doi: 10.1128/JB.00104-11. Epub 2011 Aug 5.

17.

Loss of co-chaperone TopJ impacts adhesin P1 presentation and terminal organelle maturation in Mycoplasma pneumoniae.

Cloward JM, Krause DC.

Mol Microbiol. 2011 Jul;81(2):528-39. doi: 10.1111/j.1365-2958.2011.07712.x. Epub 2011 Jun 23.

18.

Domain analysis of protein P30 in Mycoplasma pneumoniae cytadherence and gliding motility.

Chang HY, Jordan JL, Krause DC.

J Bacteriol. 2011 Apr;193(7):1726-33. doi: 10.1128/JB.01228-10. Epub 2011 Jan 21.

19.

Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae.

Lai JF, Zindl CL, Duffy LB, Atkinson TP, Jung YW, van Rooijen N, Waites KB, Krause DC, Chaplin DD.

PLoS One. 2010 Dec 23;5(12):e14417. doi: 10.1371/journal.pone.0014417.

20.

Detection of Mycoplasma pneumoniae in simulated and true clinical throat swab specimens by nanorod array-surface-enhanced Raman spectroscopy.

Hennigan SL, Driskell JD, Dluhy RA, Zhao Y, Tripp RA, Waites KB, Krause DC.

PLoS One. 2010 Oct 26;5(10):e13633. doi: 10.1371/journal.pone.0013633.

21.

Functional domain analysis of the Mycoplasma pneumoniae co-chaperone TopJ.

Cloward JM, Krause DC.

Mol Microbiol. 2010 Jul 1;77(1):158-69. doi: 10.1111/j.1365-2958.2010.07196.x. Epub 2010 May 12.

22.

Mycoplasma pneumoniae cytoskeletal protein HMW2 and the architecture of the terminal organelle.

Bose SR, Balish MF, Krause DC.

J Bacteriol. 2009 Nov;191(21):6741-8. doi: 10.1128/JB.01486-08. Epub 2009 Aug 28.

23.

Mycoplasma pneumoniae J-domain protein required for terminal organelle function.

Cloward JM, Krause DC.

Mol Microbiol. 2009 Mar;71(5):1296-307. doi: 10.1111/j.1365-2958.2009.06602.x. Epub 2009 Jan 29.

24.

Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma.

Kraft M, Adler KB, Ingram JL, Crews AL, Atkinson TP, Cairns CB, Krause DC, Chu HW.

Eur Respir J. 2008 Jan;31(1):43-6. doi: 10.1183/09031936.00103307.

25.
26.

Mycoplasma pneumoniae host-pathogen studies in an air-liquid culture of differentiated human airway epithelial cells.

Krunkosky TM, Jordan JL, Chambers E, Krause DC.

Microb Pathog. 2007 Feb-Mar;42(2-3):98-103. Epub 2007 Jan 29.

PMID:
17261358
27.
28.

Terminal organelle development in the cell wall-less bacterium Mycoplasma pneumoniae.

Hasselbring BM, Jordan JL, Krause RW, Krause DC.

Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16478-83. Epub 2006 Oct 24.

29.

Protein P200 is dispensable for Mycoplasma pneumoniae hemadsorption but not gliding motility or colonization of differentiated bronchial epithelium.

Jordan JL, Chang HY, Balish MF, Holt LS, Bose SR, Hasselbring BM, Waldo RH 3rd, Krunkosky TM, Krause DC.

Infect Immun. 2007 Jan;75(1):518-22. Epub 2006 Oct 16.

30.

Mycoplasmas: a distinct cytoskeleton for wall-less bacteria.

Balish MF, Krause DC.

J Mol Microbiol Biotechnol. 2006;11(3-5):244-55. Review.

PMID:
16983199
31.

Transposon mutagenesis identifies genes associated with Mycoplasma pneumoniae gliding motility.

Hasselbring BM, Page CA, Sheppard ES, Krause DC.

J Bacteriol. 2006 Sep;188(17):6335-45. Erratum in: J Bacteriol. 2007 Feb;189(3):1179.

32.
33.
34.
35.

HMW1 is required for stability and localization of HMW2 to the attachment organelle of Mycoplasma pneumoniae.

Willby MJ, Balish MF, Ross SM, Lee KK, Jordan JL, Krause DC.

J Bacteriol. 2004 Dec;186(24):8221-8.

36.

Predominant outer membrane antigens of Bartonella henselae.

Chenoweth MR, Greene CE, Krause DC, Gherardini FC.

Infect Immun. 2004 Jun;72(6):3097-105.

37.

Growth characteristics of Bartonella henselae in a novel liquid medium: primary isolation, growth-phase-dependent phage induction, and metabolic studies.

Chenoweth MR, Somerville GA, Krause DC, O'Reilly KL, Gherardini FC.

Appl Environ Microbiol. 2004 Feb;70(2):656-63.

38.
39.
41.
42.

Stability and subcellular localization of cytadherence-associated protein P65 in Mycoplasma pneumoniae.

Jordan JL, Berry KM, Balish MF, Krause DC.

J Bacteriol. 2001 Dec;183(24):7387-91.

43.
44.

Structure, function, and assembly of the terminal organelle of Mycoplasma pneumoniae.

Krause DC, Balish MF.

FEMS Microbiol Lett. 2001 Apr 20;198(1):1-7. Review.

45.

Transcriptional analysis of the hmw gene cluster of Mycoplasma pneumoniae.

Waldo RH 3rd, Popham PL, Romero-Arroyo CE, Mothershed EA, Lee KK, Krause DC.

J Bacteriol. 1999 Aug;181(16):4978-85.

46.
47.

Construction and analysis of a modified Tn4001 conferring chloramphenicol resistance in Mycoplasma pneumoniae.

Hahn TW, Mothershed EA, Waldo RH 3rd, Krause DC.

Plasmid. 1999 Mar;41(2):120-4.

PMID:
10087215
48.

Mycoplasma pneumoniae protein P30 is required for cytadherence and associated with proper cell development.

Romero-Arroyo CE, Jordan J, Peacock SJ, Willby MJ, Farmer MA, Krause DC.

J Bacteriol. 1999 Feb;181(4):1079-87.

49.

Bartonella henselae invasion of feline erythrocytes in vitro.

Mehock JR, Greene CE, Gherardini FC, Hahn TW, Krause DC.

Infect Immun. 1998 Jul;66(7):3462-6.

50.

Supplemental Content

Loading ...
Support Center